Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways

Oncology Letters

Volumn 12, Issue 4, 2016, Pages 2894-2899

  Zhong, Wei Feng ^a   Wang, Xiao Hong ^b   Pan, Bin ^c   Li, Feng ^d   Kuang, Lu ^b   Su, Ze Xuan ^c  

^a Department of Second Urology   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Eupatilin; Reactive oxygen species; Renal cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; EUPATILIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTEMISIA; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KIDNEY CANCER; KIDNEY CARCINOMA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84983414223     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4989     Document Type: Article

References (34)

1. Larkin J, Goh XY, Vetter M, Pickering L and Swanton C: Epigenetic regulation in RCC: Opportunities for therapeutic intervention? Nat Rev Urol 9: 147-155, 2012.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
3. Penticuff JC and Kyprianou N: Therapeutic challenges in renal cell carcimoma. Am J Clin Exp Urol 3: 77-90, 2015.
4. Salmeen A and Barford D: Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7: 560-577, 2005.
5. Waris G and Ahsan H: Reactive oxygen species: Role in the development of cancer and various chronic conditions. J Carcinog 5: 14, 2006.
6. Jang HJ, Jeong EK, Kim SS, Lee JH, Oh MY, Kang KS, Kwan HC, Song KI, Eom DW and Han DJ: Protective effect of Artemisia asiatica extract against renal ischemia-reperfusion injury in mice. Exp Clin Transplant Suppl 1: 377-82, 2015.
7. Park BB, Yoon JS, Kim ES, Choi J, Won YW, Choi JH and Lee YY: Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumor Biol 34: 875-885, 2013.
8. Kim YD, Choi SC, Oh TY, Chun JS and Jun CD: Eupatilin inhibits T-cell activation by modulation of intracellular calcium flux and NF-kappaB and NF-AT activity. J Cell Biochem 108: 225-236, 2009.
9. Choi EJ, Lee S, Chae JR, Lee HS, Jun CD and Kim SH: Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages. Life Sci 88: 1121-1126, 2011.
10. Yoon KD, Chin YW, Yang MH and Kim J: Separation of anti-ulcer flavonoids from Artemisia extracts by high-speed countercurrent chromatography. Food Chem 129: 679-683, 2011.
11. Choi EJ, Oh HM, Na BR, Ramesh TP, Lee HJ, Choi CS, Choi SC, Oh TY, Choi SJ, Chae JR, et al: Eupatilin protects gastric epithelial cells from oxidative damage and down-regulates genes responsible for the cellular oxidative stress. Pharm Res 25: 1355-1364, 2008.
12. Cho JH, Lee JG, Yang YI, Kim JH, Ahn JH, Baek NI, Lee KT and Choi JH: Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem Toxicol 49: 1737-1744, 2011.
13. Jin Y, Yang J, Lin L, Lin Y and Zheng C: The attenuation of Scutellariae radix extract on oxidative stress for colon injury in lipopolysaccharide-induced RAW264.7 cell and 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis rats. Pharmacogn Mag 12: 153-159, 2016.
14. Xiong Y, Ye T, Wang M, Xia Y, Wang N, Song X, Wang F, Liu L, Zhu Y, Yang F, et al: A novel cinnamide YLT26 induces breast cancer cells apoptosis via ROS-mitochondrial apoptotic pathway in vitro and inhibits lung metastasis in vivo. Cell Physiol Biochem 34: 1863-1876, 2014.
15. Choi EK, Yeo JS, Park CY, Na HI, Lim JA, Lee JE, Hong SW, Park SS, Lim DG and Kwak KH: Inhibition of reactive oxygen species downregulates the MAPK pathway in rat spinal cord after limb ischemia reperfusion injury. Int J Surg 22: 74-81, 2015.
16. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH and Teh BT: Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res 68: 81-88, 2008.
17. Guo H, German P, Bai S, Barnes S, Guo W, Qi X, Lou H, Liang J, Jonasch E, Mills GB and Ding Z: The PI3K/AKT pathway and renal cell carcinoma. J Genet Genomics 42: 343-353, 2015.
18. Thannickal VJ and Fanburg BL: Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
19. Essick EE and Sam F: Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev 3: 168-177, 2010.
20. Li J and Yuan J: Caspases in apoptosis and beyond. Oncogene 27: 6194-6206, 2008.
21. Tawa P, Hell K, Giroux A, Grimm E, Han Y, Nicholson DW and Xanthoudakis S: Catalytic activity of caspase-3 is required for its degradation: Stabilization of the active complex by synthetic inhibitors. Cell Death Differ 11: 439-447, 2004.
22. Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849, 2004.
23. Ballif BA and Blenis J: Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12: 397-408, 2001.
24. Liu J, Chang F, Li F, Fu H, Wang J, Zhang S, Zhao J and Yin D: Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK. Biochem Biophys Res Commun 463: 262-267, 2015.
25. Ki YW, Park JH, Lee JE, Shin IC and Koh HC: JNK and p38 MAPK regulate oxidative stress and the inflammatory response in chlorpyrifos-induced apoptosis. Toxicol Lett 218: 235-245, 2013.
26. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M and Nebreda AR: P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15: 922-933, 2004.
27. Park EJ, Park SW, Kim HJ, Kwak JH, Lee DU and Chang KC: Dehydrocostuslactone inhibits LPS-induced inflammation by p38MAPK-dependent induction of hemeoxygenase-1 in vitro and improves survival of mice in CLP-induced sepsis in vivo. Int Immunopharmacol 22: 332-340, 2014.
28. Porta C and Figlin RA: Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors. J Urol 182: 2569-2577, 2009.
29. Banumathy G and Cairns P: Signaling pathways in renal cell carcinoma. Cancer Biol Ther 10: 658-664, 2010.
30. Sourbier C, Lindner V, Lang H, Agouni A, Schordan E, Danilin S, Rothhut S, Jacqmin D, Helwig JJ and Massfelder T: The phosphoinositide 3-kinase/Akt pathway: A new target in human renal cell carcinoma therapy. Cancer Res 66: 5130-5142, 2006.
31. Brzezianska E and Pastuszak-Lewandoska D: A minireview: The role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm. Fronti Biosci (Landmark Ed) 16: 422-439, 2011.
32. Shi Y, Song Q, Hu D, Zhuang X, Yu S and Teng D: Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway. Korean J Physiol Pharmacol 20: 237-243, 2016.
33. Mi Y, Xiao C, Du Q, Wu W, Qi G and Liu X: Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways. Free Radic Biol Med 90: 230-422, 2016.
34. Hao W, Yuan X, Yu L, Gao C, Sun X, Wang D and Zheng Q: Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci Rep 5: 10336, 2015.